433 related articles for article (PubMed ID: 30367820)
21. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.
Patel NR; Aryasomayajula B; Abouzeid AH; Torchilin VP
Ther Deliv; 2015; 6(4):509-20. PubMed ID: 25996047
[TBL] [Abstract][Full Text] [Related]
22. Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids.
Lee SY; Jeong EK; Jeon HM; Kim CH; Kang HS
Oncol Rep; 2010 Jul; 24(1):73-9. PubMed ID: 20514446
[TBL] [Abstract][Full Text] [Related]
23. Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing.
Voissiere A; Jouberton E; Maubert E; Degoul F; Peyrode C; Chezal JM; Miot-Noirault É
PLoS One; 2017; 12(7):e0181340. PubMed ID: 28704566
[TBL] [Abstract][Full Text] [Related]
24. Tumor spheroid assembly on hyaluronic acid-based structures: A review.
Carvalho MP; Costa EC; Miguel SP; Correia IJ
Carbohydr Polym; 2016 Oct; 150():139-48. PubMed ID: 27312623
[TBL] [Abstract][Full Text] [Related]
25. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays.
Tofani LB; Abriata JP; Luiz MT; Marchetti JM; Swiech K
Biotechnol Prog; 2020 Nov; 36(6):e3034. PubMed ID: 32519461
[TBL] [Abstract][Full Text] [Related]
26. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
Guo WM; Loh XJ; Tan EY; Loo JS; Ho VH
Mol Pharm; 2014 Jul; 11(7):2182-9. PubMed ID: 24842574
[TBL] [Abstract][Full Text] [Related]
27. Impact of the spheroid model complexity on drug response.
Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
[TBL] [Abstract][Full Text] [Related]
28. Development of an
Lee J; Shin D; Roh JL
Theranostics; 2018; 8(14):3964-3973. PubMed ID: 30083273
[TBL] [Abstract][Full Text] [Related]
29. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
Karlsson H; Fryknäs M; Larsson R; Nygren P
Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
[TBL] [Abstract][Full Text] [Related]
30. Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids.
Rodríguez CE; Reidel SI; Bal de Kier Joffé ED; Jasnis MA; Fiszman GL
PLoS One; 2015; 10(9):e0137920. PubMed ID: 26360292
[TBL] [Abstract][Full Text] [Related]
31. PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumors.
Steadman K; Stein WD; Litman T; Yang SX; Abu-Asab M; Dutcher SK; Bates S
Cell Cycle; 2008 Mar; 7(6):818-29. PubMed ID: 18239467
[TBL] [Abstract][Full Text] [Related]
32. Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models.
Filipiak-Duliban A; Brodaczewska K; Kajdasz A; Kieda C
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163092
[TBL] [Abstract][Full Text] [Related]
33. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids.
Herrmann R; Fayad W; Schwarz S; Berndtsson M; Linder S
J Biomol Screen; 2008 Jan; 13(1):1-8. PubMed ID: 18040052
[TBL] [Abstract][Full Text] [Related]
34. Development of an in vitro 3D tumor model to study therapeutic efficiency of an anticancer drug.
Shin CS; Kwak B; Han B; Park K
Mol Pharm; 2013 Jun; 10(6):2167-75. PubMed ID: 23461341
[TBL] [Abstract][Full Text] [Related]
35. Mini-pillar array for hydrogel-supported 3D culture and high-content histologic analysis of human tumor spheroids.
Kang J; Lee DW; Hwang HJ; Yeon SE; Lee MY; Kuh HJ
Lab Chip; 2016 Jun; 16(12):2265-76. PubMed ID: 27194205
[TBL] [Abstract][Full Text] [Related]
36. Issues with Cancer Spheroid Models in Therapeutic Drug Screening.
Fröhlich E
Curr Pharm Des; 2020; 26(18):2137-2148. PubMed ID: 32067603
[TBL] [Abstract][Full Text] [Related]
37. Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs.
Schreiber-Brynzak E; Klapproth E; Unger C; Lichtscheidl-Schultz I; Göschl S; Schweighofer S; Trondl R; Dolznig H; Jakupec MA; Keppler BK
Invest New Drugs; 2015 Aug; 33(4):835-47. PubMed ID: 26091914
[TBL] [Abstract][Full Text] [Related]
38. Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs.
Moskovits N; Itzhaki E; Tarasenko N; Chausky E; Bareket-Samish A; Kaufman A; Meerson R; Stemmer SM
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591992
[TBL] [Abstract][Full Text] [Related]
39. Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids.
Durand RE; Olive PL
Methods Cell Biol; 2001; 64():211-33. PubMed ID: 11070841
[No Abstract] [Full Text] [Related]
40. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
